AR-V7 has been associated with poor prognosis in PCa metastatic to the bones [31], increased risk of biochemical disease recurrence after radical prostatectomy [32], and progression supporting epithelial-to-mesenchymal transition that contributes to metastatic spreading [33]. The gene discussed is AR; the disease is posterior cortical atrophy.